Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers.
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FORBES-TATE
- Client
- WALGREENS CO.
- Filing UUID
- 772dc920-d51b-4d8a-8850-b6af8131896d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
Issues related to corporate tax, net operating loss, EBITA/EBIDA.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.